280 related articles for article (PubMed ID: 34009232)
1. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors.
Abdel-Qadir H; Singh SM; Pang A; Austin PC; Jackevicius CA; Tu K; Dorian P; Ko DT
JAMA Cardiol; 2021 Aug; 6(8):918-925. PubMed ID: 34009232
[TBL] [Abstract][Full Text] [Related]
2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
4. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
5. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
6. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
Lip GYH; Banerjee A; Boriani G; Chiang CE; Fargo R; Freedman B; Lane DA; Ruff CT; Turakhia M; Werring D; Patel S; Moores L
Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
[TBL] [Abstract][Full Text] [Related]
8. Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation.
Shah SJ; Eckman MH; Aspberg S; Go AS; Singer DE
Ann Intern Med; 2018 Oct; 169(8):517-527. PubMed ID: 30264130
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.
Apenteng PN; Gao H; Hobbs FR; Fitzmaurice DA;
BMJ Open; 2018 Jan; 8(1):e018905. PubMed ID: 29331969
[TBL] [Abstract][Full Text] [Related]
11. Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis.
Walkey AJ; Quinn EK; Winter MR; McManus DD; Benjamin EJ
JAMA Cardiol; 2016 Sep; 1(6):682-90. PubMed ID: 27487456
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex).
Xie X; Li T
Acta Cardiol; 2021 May; 76(3):258-264. PubMed ID: 32056508
[TBL] [Abstract][Full Text] [Related]
13. The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study.
Lip GYH; Nielsen PB; Skjøth F; Lane DA; Rasmussen LH; Larsen TB
Chest; 2014 Nov; 146(5):1337-1346. PubMed ID: 25086251
[TBL] [Abstract][Full Text] [Related]
14. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
15. Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting.
Taha A; Nielsen SJ; Franzén S; Rezk M; Ahlsson A; Friberg L; Björck S; Jeppsson A; Bergfeldt L
J Am Heart Assoc; 2022 May; 11(10):e024703. PubMed ID: 35574947
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
17. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
Dupree L; DeLosSantos M; Smotherman C
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
[TBL] [Abstract][Full Text] [Related]
19. Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
Fauchier L; Clementy N; Bisson A; Ivanes F; Angoulvant D; Babuty D; Lip GY
Stroke; 2016 Jul; 47(7):1831-6. PubMed ID: 27231269
[TBL] [Abstract][Full Text] [Related]
20. CHA
Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
